Low-risk prostate tumors reveal molecular signs linked to more aggressive cancer
A new study revealed molecular features linked to more aggressive prostate cancer in a subset of patients who had been classified as low risk, highlighting biological differences that may not be apparent from clinical measures alone. The results could lead to new therapeutic strategies.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Novel radiotherapy may save increasingly many rectal cancer patients from surgery and a stoma
United Kingdom
-
Maternal vaccines protect babies from serious infections, but unequal access limits benefits across Europe
United Kingdom
-
Scientists identify the neuroblastoma cells that signal poor outcomes
United Kingdom
-
'Immune fog' may flag lung cancer risk years before tumor develops
United Kingdom
-
Peanut consumption affects the lipid profile circulating in the blood
United Kingdom
-
Abdominal fluid reveals rare immune cells that may limit attacks on tumors
United Kingdom
-
Electrical ablation boosts CAR-NK cell therapy against liver cancer, offering new strategy for refractory solid tumors
United Kingdom
-
A self-disinfecting fabric eliminates bacteria, fungi and viruses in hospital settings
United Kingdom